Semaglutide showdown: Natco challenges Novo Nordisk patent

📅 Published: January 6, 2026 | 📂 Category: Uncategorized

Natco’s escalates the legal battle over semaglutide, one of the world’s most valuable and closely contested pharmaceutical drugs.

Read more

📱 Share on WhatsApp 🌐 View Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *